NCT06820658 A Comparison of Neuromuscular Recruitment in Trained and Untrained Adults
| NCT ID | NCT06820658 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Healthy |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-02-26 |
| Primary Completion | 2028-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2025-02-26 with a primary completion date of 2028-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of the study is to use neurological techniques to obtain quantitative measurements of nervous system control of skeletal muscle activity in adults aged 60-85 who are either long-term resistance exercisers or who are untrained.
Eligibility Criteria
Inclusion Criteria * Participant must have a BMI between 18.5 and 38 * Participant be aged between 60 and 85 * Regularly exercises at least 5 days a week a minimum of 30 minutes per day. * Engages in less than 2 days of exercise less than 30 minutes each day. * Participant must use the Mayo Clinic patient online portal. * Participant must be able to understand English without the need of an interpreter. * Must be willing to be contacted for research * Participant must be willing and capable to provide consent. * Participants shall be generally healthy as deemed acceptable by the principal investigator * Men and women will be participant in this study. Women cannot be pregnant during this study. Exclusion Criteria: * Surgical History - Gastric surgery, pacemaker placement, weight loss surgery, metabolic and obstetric surgery. * Smokers will be excluded from the study. * Medications: Insulins, common diabetic drugs, anti-hyperglycemic drugs, beta blockers cardiac selective, beta-blockers noncardiac selective, oral steroids, opioids anti-depressants, and hormones * Conidiations and Diagnosis: Disorder of coronary artery, hepatic failure, gastroparesis, disorder of the adrenal gland, drug related disorders, substance abuse, malignant neoplastic disease, psychotic disorders, disorder of skeletal muscle, finding of brain, chronic kidney disease, renal failure syndrome, disorder of pulmonary circulation, cerebrovascular disease, neuro developmental disorder, disorder of immune function, disorder of central nervous system. * Participants are not to have an abnormal value as part of a lipid panel within the past 6 months. * Participant will be excluded if they have recreational drug use or a history of alcohol abuse * Inability or unwillingness of individual or legal guardian/representative to give written informed consent. * Current or past participation within a specified timeframe in another clinical trial, as warranted by the administration of this intervention. * Participant will be excluded if they have epilepsy. * Participant will be excluded if they have cranial metal/device implants * Participant will be excluded if they are pregnant
Contact & Investigator
K. S. Nair, M.D., Ph.D.
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06820658 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 85 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06820658 currently recruiting?
Yes, NCT06820658 is actively recruiting participants. Contact the research team at Gupta.Devanshi@mayo.edu for enrollment information.
Where is the NCT06820658 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT06820658 clinical trial?
NCT06820658 is sponsored by Mayo Clinic. The principal investigator is K. S. Nair, M.D., Ph.D. at Mayo Clinic. The trial plans to enroll 80 participants.